Developing a new drug or biologic is a complex process. Based on our extensive experience advising early-stage and clinical-stage companies, the Goodwin FDA team created this “scorecard” for companies to use as a guide as they navigate the FDA drug development and approval process. The drug development scorecard (or checklist) can help companies keep track of progress, identify opportunities, and achieve milestones that are appropriate for each stage of development.
If you have product development or approval strategy questions, we encourage you to contact the Goodwin FDA team.
The post Drug Development Scorecard — A Guide for Companies Navigating the FDA Drug and Biologic Development and Approval Process appeared first on Life Sciences Perspectives.